These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23819360)

  • 41. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
    Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
    AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer.
    Wu X; Reinikainen P; Vanhanen A; Kapanen M; Vierikko T; Ryymin P; Hyödynmaa S; Kellokumpu-Lehtinen PL
    Diagn Interv Imaging; 2017 Jan; 98(1):63-71. PubMed ID: 27687831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
    Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
    Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Objective Value of the Apparent Diffusion Coefficient (ADC) Map from Ultrahigh b-value Diffusion-weighted Imaging (DWI) in 3T MRI could be a Non-invasive Specific Biomarker for Prostate Cancer.
    Zhang K; Zhang C; Chen Z; Zhang Y; Dong Z; Hu Y; Wang M; Fu Y; Ye H; Shen Y
    Curr Med Imaging; 2023 Jul; ():. PubMed ID: 37464833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]   [Full Text] [Related]  

  • 48. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging.
    Woo S; Cho JY; Kim SY; Kim SH
    AJR Am J Roentgenol; 2015 Feb; 204(2):W168-75. PubMed ID: 25615777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.
    Kato S; Kamijima S; Inaoka T; Kamiya N; Sasai D; Terada H; Hiruta N; Suzuki H
    Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.
    Lin WC; Westphalen AC; Silva GE; Chodraui Filho S; Reis RB; Muglia VF
    Abdom Radiol (NY); 2016 Nov; 41(11):2209-2217. PubMed ID: 27364781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI.
    Barbieri S; Brönnimann M; Boxler S; Vermathen P; Thoeny HC
    Eur Radiol; 2017 Apr; 27(4):1547-1555. PubMed ID: 27300199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
    Kido A; Tamada T; Sone T; Kanomata N; Miyaji Y; Yamamoto A; Ito K
    Radiol Med; 2017 Mar; 122(3):228-238. PubMed ID: 27943099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
    Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
    J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.
    Hötker AM; Mazaheri Y; Aras Ö; Zheng J; Moskowitz CS; Gondo T; Matsumoto K; Hricak H; Akin O
    AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation.
    Rosenkrantz AB; Khalef V; Xu W; Babb JS; Taneja SS; Doshi AM
    Clin Radiol; 2015 Sep; 70(9):1032-7. PubMed ID: 26126712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-weighted signal models in healthy and cancerous peripheral prostate tissues: comparison of outcomes obtained at different b-values.
    Mazzoni LN; Lucarini S; Chiti S; Busoni S; Gori C; Menchi I
    J Magn Reson Imaging; 2014 Mar; 39(3):512-8. PubMed ID: 23723087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients.
    Caivano R; Rabasco P; Lotumolo A; Cirillo P; D'Antuono F; Zandolino A; Villonio A; Macarini L; Salvatore M; Cammarota A
    Cancer Invest; 2013 Nov; 31(9):625-9. PubMed ID: 24138289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.